For some medical complaints, open-label placebos work just as well as deceptive ones. As psychologists from the University of Basel and Harvard Medical School report in the journal Pain, the accompanying rationale plays an important role when administering a placebo.
Some patients may have a genetic risk of developing a serious side effect to a type of medication commonly used to treat high blood pressure, research by clinicians and scientists at the University of Nottingham has found.
Stroke patients who stopped taking statin drugs three to six months after a first ischemic stroke, the type caused by narrowed arteries, had a higher risk of a having another stroke within a year, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
A group of researchers from diverse Spanish public entities, including UPM, has developed the bases of a new model to better classify patients when it comes to prescribing anabolic hormone supplementation.
Researchers from the University of Pittsburgh Schools of the Health Sciences and UPMC have uncovered the molecular mechanism underlying corticosteroid resistance in severe asthma. The new findings have important clinical implications, suggesting that corticosteroids, the main treatment for asthma, may worsen the disease in this group of patients.
Available without prescription and with fewer side effects than acetazolamide and ibuprofen, acetaminophen is effective, according to the latest issue of Wilderness & Environmental Medicine